193 related articles for article (PubMed ID: 10082496)
1. Enhancement of bradykinin and resensitization of its B2 receptor.
Marcic B; Deddish PA; Jackman HL; Erdös EG
Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.
Marcic BM; Erdös EG
J Pharmacol Exp Ther; 2000 Aug; 294(2):605-12. PubMed ID: 10900238
[TBL] [Abstract][Full Text] [Related]
4. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
[TBL] [Abstract][Full Text] [Related]
5. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
[TBL] [Abstract][Full Text] [Related]
6. Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
Chen Z; Tan F; Erdös EG; Deddish PA
Hypertension; 2005 Dec; 46(6):1368-73. PubMed ID: 16246972
[TBL] [Abstract][Full Text] [Related]
7. Effects of the N-terminal sequence of ACE on the properties of its C-domain.
Marcic B; Deddish PA; Jackman HL; Erdös EG; Tan F
Hypertension; 2000 Jul; 36(1):116-21. PubMed ID: 10904022
[TBL] [Abstract][Full Text] [Related]
8. Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor.
Deddish PA; Marcic BM; Tan F; Jackman HL; Chen Z; Erdös EG
Hypertension; 2002 Feb; 39(2 Pt 2):619-23. PubMed ID: 11882619
[TBL] [Abstract][Full Text] [Related]
9. Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin.
Gobeil F; Hallé S; Blais PA; Regoli D
Can J Physiol Pharmacol; 2002 Feb; 80(2):153-63. PubMed ID: 11934258
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
11. Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.
Erdös EG; Jackman HL; Brovkovych V; Tan F; Deddish PA
J Mol Cell Cardiol; 2002 Dec; 34(12):1569-76. PubMed ID: 12505055
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
Rodrigues MS; Schaffel R; Assreuy J
Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
[TBL] [Abstract][Full Text] [Related]
14. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.
Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
J Biol Chem; 2002 May; 277(19):16847-52. PubMed ID: 11880373
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
[TBL] [Abstract][Full Text] [Related]
16. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.
Scharfstein J; Schmitz V; Morandi V; Capella MM; Lima AP; Morrot A; Juliano L; Müller-Esterl W
J Exp Med; 2000 Nov; 192(9):1289-300. PubMed ID: 11067878
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
Hecker M; Benzing T; Busse R
Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum.
Minshall RD; Nedumgottil SJ; Igić R; Erdös EG; Rabito SF
Peptides; 2000 Aug; 21(8):1257-64. PubMed ID: 11035213
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein activates bradykinin B2 receptors in absence of kininogen.
Biyashev D; Tan F; Chen Z; Zhang K; Deddish PA; Erdös EG; Hecquet C
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1244-50. PubMed ID: 16272198
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
